Tim Powell is a partner of Powell Gilbert LLP, a specialist IP law firm based in London. He has a strong technical background that has enabled him to represent clients in some of the largest and most complex IP disputes to come before the UK courts in recent years.
Mr Powell specialises in multi-jurisdictional litigation, particularly in the patents field, where he has experience in coordinating litigation taking place simultaneously across Europe, North America and beyond. He also advises clients on healthcare regulatory issues.
His cases include Chiron v Murex (hepatitis C virus); Pharmacia v Merck (Cox 2 inhibitors); Yeda v Sanofi Aventis (monoclonal antibodies); Affymetrix v Multilyte (DNA microarrays); Philips v Princo (CD-R technology); Unilever v Colgate (packaging technology); Novartis (European Court of Justice, EU Supplementary Protection Certificate (SPC) Regulation); Phillips Petroleum v ExxonMobil (petrochemicals); Monsanto v Cargill (genetically modified crops); Yeda v Comptroller General of Patents (SPC Regulation); Nokia v Apple (smartphone technology); BSN v Mölnlycke (advanced wound care); Cisco Systems v Comptel (software licensing); Motorola v Microsoft (smartphone technology); Vringo v ZTE (telecommunications infrastructure); Actavis v Warner Lambert (second medical use patent); Edwards Lifesciences v Boston Scientific (heart valves); and Illumina v Premaitha (NIPT technology).
Mr Powell is a solicitor advocate and has represented clients as an advocate in the UK and European Patent Offices, the English High Court, the Court of Appeal, the House of Lords and the European Court of Justice. He is a member of the Intellectual Property Advisory Committee of the UK BioIndustry Association and a board member of the Intellectual Property Lawyers’ Association.
Register for more free content
- Read more IAM blogs and articles
- Receive the editor's weekly review by email